Brand new Energy re-sale distributor is recalling all lot codes of EphBurn 25. The FDA has notified them that one lot of EphBurn 25 was sampled and found to contain ephedrine alkaloids, making it an unapproved drug.
Ephedrine is a stimulant, appetite suppressant, concentration aid, and decongestant. Adverse effects of this drug include elevated blood pressure, rapid heartbeat, nerve damage, muscle injury, psychosis, and memory loss. More serious side effects include heart attack, stroke, seizure, and death. But there have been no reports of adverse events associated with the consumption of this product.
The recall affects all lot codes and use-by dates of EphBurn 25. The product is a 90-count bottle with red capsules. It displays the product name “ephBURN 25” in white letters on a red label. There is no UPC code. EphBurn 25 was discontinued on or about May 2012.
If you have purchased this product, immediately discontinue use. Contact your healthcare provider if you have experienced any problems. Report adverse side effects at Medwatch. For questions, call 1-888-234-2595 from 8:00 am to 4:00 pm PT.
